Colorectal cancer profiling by multiplex detection
Driven by FDA, NCCN and ASCO guidelines, our COLONSEQ and COLONSEQPlus testing results associate Standard of Care or clinical trial therapeutics specific to colorectal cancers with a focus on prioritization and support of treatment planning for the physician.
- Comprehensive and integrated services mobilizing complete workups by IHC or Next Generation Sequencing
- Available individual markers, reflexive offerings, and flexible testing designed to meet the cost efficiencies and clinical needs for the patient and physician
- In-network with most managed care providers